Conor Kilroy
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Conor Kilroy is currently Secretary & Chief Legal Officer at Aura Biosciences, Inc., starting in 2025.
Former positions include Secretary & General Counsel at Neurogastrx, Inc. from 2021 to 2023; Secretary, Senior Vice President & General Counsel at Ironwood Pharmaceuticals, Inc. from 2020 to 2021; Counsel at Boston Scientific Corp.
from 2012 to 2013; and Associate at Goodwin Procter LLP from 2007 to 2011.
Education includes undergraduate studies at Brandeis University and graduate studies at Boston College Law School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,37 % | 01.07.2026 | 232.693 ( 0,37 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AURA BIOSCIENCES, INC. | General Counsel | 01.04.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | General Counsel | 01.05.2023 |
| IRONWOOD PHARMACEUTICALS, INC. | General Counsel | 01.02.2021 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.01.2013 |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01.01.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen